SCHEMBL19885485

SCHEMBL19885485

c1ccc(-c2ccccc2N(c2ccc(-c3ccc4oc5ccccc5c4c3)cc2)c2ccc3c(c2)-c2ccccc2Oc2ccccc2-3)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.36
▸ PLA2G4A P47712 4/20 0.36
▸ HSP90AA1 P07900 1/20 0.33
▸ HSP90AB1 P08238 1/20 0.33
▸ PLA2G10 O15496 1/20 0.33
▸ MEN1 O00255 2/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ MAPT P10636 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HPGD P15428 1/20 0.32
▸ APAF1 O14727 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ THRB P10828 1/20 0.32
▸ XBP1 P17861 1/20 0.32
▸ PTBP1 P26599 1/20 0.32
▸ HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19885412 0.92 PLA2G2A (0.40) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL19888554 0.92 PLA2G2A (0.40) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL19885393 0.90 MAPT (0.37) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL19885437 0.90 MAPT (0.37) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL19885410 0.89 MAPT (0.36) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL19885392 0.89 NPC1 (0.36) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL18212124 0.89 PLA2G2A (0.42) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL19598814 0.89 PLA2G2A (0.44) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL18212084 0.89 PLA2G2A (0.44) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10
SCHEMBL18212076 0.89 PLA2G2A (0.44) PLA2G2APLA2G4AHSP90AA1HSP90AB1PLA2G10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10396292-B2 Compound and organic electronic device using the same SHANGHAI NICHEM FINE CHEMICAL CO., LTD. (CN) 2019-08-27 — — US disclosed
US-20180053899-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-22 — — US disclosed
US-20180053899-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME NICHEM FINE TECHNOLOGY CO., LTD. (TW) 2018-02-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10396292-B2 Compound and organic electronic device using the same OR51E2, OR10J3, ESR1 PLA2G2A 4709/4885PLA2G4A 4814/4885HSP90AA1 4769/4885
US-20180053899-A1 COMPOUND AND ORGANIC ELECTRONIC DEVICE USING THE SAME OR51E2, OR10J3, ESR1 PLA2G2A 4709/4885PLA2G4A 4814/4885HSP90AA1 4769/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback